Latest news
Viatris Lifts 2026 Outlook After Strong Second Quarter - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 12:34:00 GMTVTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook - StockStoryStockStory · Fri, 07 Aug 2026 07:00:00 GMTViatris reports Q2 adjusted EPS 69c, consensus 60c - TipRanksTipRanks · Thu, 06 Aug 2026 23:15:14 GMTACOG & ISSWSH continue to drive women's health forward - Contemporary OB/GYNContemporary OB/GYN · Wed, 05 Aug 2026 19:38:09 GMTJeffrey Jensen, MD, contextualizes contraceptive efficacy in modern trials - Contemporary OB/GYNContemporary OB/GYN · Tue, 04 Aug 2026 21:22:36 GMTFDA approval of Gwyn Lo contraceptive patch - Contemporary OB/GYNContemporary OB/GYN · Mon, 03 Aug 2026 21:25:30 GMTRegulatory round-up: 3 August 2026 - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 08:45:47 GMTViatris (VTRS) Wins FDA Approval For Gwyn Lo Contraceptive Patch - Yahoo FinanceYahoo Finance · Sun, 02 Aug 2026 17:13:42 GMT